Commentary
Podcast
Thanks for your interest in this podcast. Please read this important program information before listening.
Episode Description
The lacrimal functional unit, which includes the lacrimal glands and meibomian glands, can be stimulated via the trigeminal nerve to trigger production of the tear film. This approach can be used to manage dry eye disease (DED) in patients undergoing corneal refractive surgery. In this podcast, an expert explores opportunities to use this approach to treat patients with DED.
Acknowledgment of Educational Grant Support
This activity is supported by educational grants from Viatris, Inc, and Nordic Pharma, Inc.
Chair:
Zeba A. Syed, MD
Associate Professor of Ophthalmology
Cornea Fellowship Director
Willis Eye Hospital
Philadelphia, PA
Disclosure: Grant/Research Support: Dompé; Consultant: BioTissue, Bruder, Glaukos, Recordati Rare Diseases; Speakers Bureau: BioTissue, Recordati Rare Diseases, Tarsus; Other: BioLattice.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Release Date
May 30, 2025
Expiration Date
May 30, 2026
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.